Suppr超能文献

抗生素靶标酶修饰的抗生素耐药性。

Antibiotic Resistance by Enzymatic Modification of Antibiotic Targets.

机构信息

David Braley Centre for Antibiotic Discovery, Michael G. DeGroote Institute for Infectious Disease Research, Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, ON L8N 3Z5, Canada.

David Braley Centre for Antibiotic Discovery, Michael G. DeGroote Institute for Infectious Disease Research, Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, ON L8N 3Z5, Canada.

出版信息

Trends Mol Med. 2020 Aug;26(8):768-782. doi: 10.1016/j.molmed.2020.05.001. Epub 2020 Jun 1.

Abstract

Antibiotic resistance remains a significant threat to modern medicine. Modification of the antibiotic target is a resistance strategy that is increasingly prevalent among pathogens. Examples include resistance to glycopeptide and polymyxin antibiotics that occurs via chemical modification of their molecular targets in the cell envelope. Similarly, many ribosome-targeting antibiotics are impaired by methylation of the rRNA. In these cases, the antibiotic target is subjected to enzymatic modification rather than genetic mutation, and in many instances the resistance enzymes are readily mobilized among pathogens. Understanding the enzymes responsible for these modifications is crucial to combat resistance. Here, we review our current understanding of enzymatic modification of antibiotic targets as well as discuss efforts to combat these resistance mechanisms.

摘要

抗生素耐药性仍然是现代医学的重大威胁。抗生素靶标修饰是病原体中越来越普遍的耐药策略。例如,通过化学修饰细胞包膜中分子靶标而产生的糖肽类和多粘菌素类抗生素耐药性。同样,许多核糖体靶向抗生素因 rRNA 的甲基化而受到损害。在这些情况下,抗生素靶标受到酶修饰而不是基因突变的影响,并且在许多情况下,耐药酶在病原体之间很容易转移。了解这些修饰所涉及的酶对于对抗耐药性至关重要。在这里,我们回顾了我们对抗生素靶标酶修饰的理解,并讨论了对抗这些耐药机制的努力。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验